Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SNARE complex of the neuromuscular junction is a multi-protein assembly crucial for mediating the fusion of synaptic vesicles with the presynaptic plasma membrane, enabling neurotransmitter (acetylcholine) release required for muscle contraction. The core neuronal SNARE complex is composed of three proteins: synaptobrevin (also known as VAMP, present on synaptic vesicles), syntaxin-1, and SNAP-25 (both located at the plasma membrane)[2][4][5][6]. Formation of a tight four-helix bundle by these proteins brings vesicle and cell membranes into close proximity, overcoming energy barriers to membrane fusion and permitting rapid, calcium-triggered exocytosis[1][5][6][8]. At the neuromuscular junction, the SNARE machinery is essential for tethering, docking, and priming synaptic vesicles; upon arrival of an action potential, calcium influx triggers conformational changes—often mediated by synaptotagmin—that drive fusion and neurotransmitter release[3][2][4][5]. Disruption of the SNARE machinery (e.g., by botulinum or tetanus neurotoxins, which selectively cleave SNARE proteins) blocks synaptic transmission and leads to muscle paralysis[3][5]. While SNARE proteins are critical for neuromuscular junction physiology, the term “neuromuscular junction SNARE complex” is not a standard molecular name; the complex itself is a molecular machine, not a single protein or classic therapeutic target, but its components can individually serve as drug targets (e.g., botulinum toxin targeting synaptobrevin/VAMP)[5][6]. Further, SNARE protein gene variants are linked to neurological and neuropsychiatric disorders, and their dysfunction may contribute to a range of diseases affecting synaptic transmission[1][4][5].
Proteolytic cleavage of SNARE proteins blocking neurotransmitter release (Botulinum/tetanus toxins)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SNARE complex of the neuromuscular junction (SNARE complex (NMJ)).